메뉴
메뉴

ARGES PRIVATE EQUITY

Extensive experiences, averaging over 16 years as portfolio managers & analysts

Close relationship with limited partners based on our wide network

Pursuing growth capital strategy, aiming for sustainable growth of investment target companies

01

About ARGES

Origin of the Corporate Name
‘ARGES’, whose name means “bright”, was the third of the Cyclopes brothers in Greek mythology. Cyclopes provided Zeus thunderbolt. Zeus used their gift to defeat the Titans and became the new ruler of Mount Olympus. Thunderbolt, Cyclopes provided, symbolizes our differentiated professionalism. The act of giving thunderbolt to Zeus means trust and communication we have with our clients.
Philosophy
With our expertise in finding opportunities and deal executions, we are to create sustainable values by achieving strategic and financial goals of our clients
Vision
We want to contribute to the financial market and the community with our professionalism and sustainable profit
Goal
To be exceptionally specialized in seizing opportunities and deal executions. To be trusted by both investors and investment target companies. To share our growth with the financial market and the community.
Values
Professionalism
Professionalism
We value professionalism based on our extensive experience and knowledge, which enable us to find great opportunities and fulfill needs of our clients.
Communication
Communication
We value long-term relationships with our clients and encourage open communication to minimize conflicts of interests.
Trust
Trust
We believe trust is our greatest asset. We honor our commitments and responsibilities to our clients.
Creating Shared Value(CSV)
Creating Shared Value(CSV)
We believe that sharing our growth with others will return with more opportunities and sustainability.
02

How We Do

Key Investment Strategy
Key investment strategy of ARGES Private Equity is to make growth focused investments in exceptional companies to maximize our investors return. ARGES Private Equity has investment professionals with extensive career backgrounds, enabling us to analyze and identify potential companies. We try multidirectional approach, understanding that the projections of companies do not solely depend on visible financial statistics. We invest in companies who share mutual understanding about growth and management strategies, which also can minimize the risk of potential conflicts. For exceptional companies we find, we offer maximized amicable solutions with less engagements. We provide optimal capital or consultations to companies who seek to realize growth potentials through, for example, capital expenditure or M&A. Our goal is to maximize long-term returns by pursuing long-term harmony and favorable cooperation system with our business partners. We are patient and cooperative until companies successfully enhance their business performances and firm values. At the right time, we seek for our investment returns by reasonable and corporate-friendly means.
Investment Criteria
Key Attributes
Key Attributes
Potential companies with significant market opportunity or proven business model on demand
Investment Type
Investment Type
Ordinary stock, RCPS, CB (financial leverage if appropriate)
Transactional Purpose
Transactional Purpose
Expansion capital, Recapitalization, Acquisitions, White knight deal
Involvement Type
Involvement Type
Private Equity Fund with a board seat
Investment Process
  • Deal Sourcing
    Deal Sourcing

    Intimate corporate access to potential companies

    Valuation and growth potential analysis

  • Investment
    Investment

    Optimal suggestions with financial supports

    Thorough planning with scenario analyses

  • Value Creation
    Value Creation

    Long-term strategic management proposals to enhance firm value

    Financing schemes for stable management & ownership structure

  • Exit
    Exit

    Long-term plan for optimal returns

    Consideration on target asset liquidity for exit-plan

03

Portfolio

  • 2018
    EuBiologics|Project Fund|30 billion KRW
  • 2018
    MegaGen Implant|Project Fund|10 billion KRW
  • 2017
    PHARMA Research Bio|IB Advisory|-
  • 2016
    APSystem|Project Fund|60 billion KRW
신한금융투자
SK증권
이베스트투자증권
유진투자증권
키움투자자산운용
신한캐피탈
KDB캐피탈
효성캐피탈
TIMEFOdivO
포스코기술투자
ARK Impact
MIDAS ASSET
미래에셋대우
하나금융투자
JS Asset
04

Team

Our team at ARGES Private Equity consists of investment professionals who have aligning interests. Members share not only the knowledge and experience but also the same Philosophy and Vision to work as a team

Managing Partners

Sean Kim, CEO

  • Sean Kim is an Outside Director of APS Holdings(A054620), a Non-executive Director of MegaGen Implant, and a Visiting Professor at Konkuk University.
    Before the foundation, Mr. Kim was an Equity Fund Manager at Shinhan BNP Paribas Asset Management. Also, he was an Equity Fund Manager at Truston Asset Management and was an Analyst at Research Center of Daewoo Securities. Mr. Kim has been working in the financial industry over 17 years.
    He received a BA and an MBA from Seoul National University.

Kevin Ghill, Executive Vice President

  • Kevin Ghill is a visiting Professor at Korea Banking Institute.
    Before joining ARGES, he was a Division Director of Multi Investment Solution Division at Shinhan BNP Paribas Asset Management. Prior to this, he worked at Samsung Securities as a Derivative Wrap Investment Manager, Korea Investment & Securities as a Financial Derivatives Fund Manager. Mr. Ghill has over 18 years of experience as a manger.
    Mr. Ghill has a BA in Applied Statistics from Yonsei University, MBA &Ph.D.(course completion) in Financial Engineering from KAIST Graduate school of management, and a Ph.D.(course completion) in Consumer Finance from Seoul National University.

SD Kim, Executive Managing Director

  • Prior to joining ARGES, SD Kim was a Division Director of Pension Fund Department in Mirae Asset Global Investments. Before this, he worked as a Senior Analyst at Research Center of Korea Investment & Securities, an Analyst at Research Center of KB Securities, and a Fixed Income Fund Manager at Samsung Life Insurance
    Mr. Kim received a BA in Business Administration from Yonsei University.
05

Contact

지도

Address

ARGES Private Equity, Inc.
6F Opulence Bldg., 254,
Seocho-daero, Seocho-gu,
Seoul, Republic of Korea

Email

arges@arges.co.kr

Tel +82-2-6407-2901
Fax +82-2-6407-2904